Do women with impaired sexual function following oophorectomy benefit from transdermal testosterone at a physiologic dose?
Reynolds
P L
PL
St. Louis University, Family Practice Residency, Belleville, Illinois, USA. peter.reynolds@medgrp.scott.af.mil
D000279:Administration, Cutaneous; D000328:Adult; D000339:Affect / Q000187:drug effects; D000704:Analysis of Variance; D018592:Cross-Over Studies; D004311:Double-Blind Method; D015914:Estrogen Replacement Therapy; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D010052:Ovariectomy / Q000009:adverse effects*; D010919:Placebos; D012725:Sexual Behavior / Q000187:drug effects; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy* / Q000209:etiology; D013739:Testosterone / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D010919:Placebos; D013739:Testosterone